Ameritas Investment Partners’s Applied Genetic Technologies Corporation AGTC Stock Holding History

Ameritas Investment Partners’s Portfolio AGTC Stock Details AGTC Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2021 Q2	–	Sell	-3,532	Closed	-$18K	–	3308
2021 Q1	$18K	Buy	3,532 +1,470	+71%	+$7.63K	﹤0.01%	2621
2020 Q4	$8K	Hold	2,062	–	–	﹤0.01%	2899
2020 Q3	$10K	Hold	2,062	–	–	﹤0.01%	2739
2020 Q2	$11K	Buy	+2,062	New	+$9.44K	﹤0.01%	2694
2017 Q2	–	Sell	-989	Closed	-$7K	–	3074
2017 Q1	$7K	Buy	+989	New	+$7.73K	﹤0.01%	2793

Other funds holding AGTC

Millennium Management New York $240B AUM 35.51% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

IVM

InterWest Venture Management San Francisco, California $20.6M AUM 48.5% 1-Year Est. Return

PCM

Portolan Capital Management Boston, Massachusetts $1.88B AUM 115.74% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return

Assenagon Asset Management Senningerberg, Luxembourg $80.2B AUM 50.57% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Jacobs Levy Equity Management Florham Park, New Jersey $23.8B AUM 25.4% 1-Year Est. Return

Ikarian Capital Dallas, Texas $1.23B AUM 600.17% 1-Year Est. Return

Ameritas Investment Partners's AGTC Position: Q2 2021 in Review

Ameritas Investment Partners sold out of Applied Genetic Technologies Corporation (AGTC) in Q2 2021, closing a stake of 3,532 shares — an estimated $18K sold.

Ameritas Investment Partners first reported a position in AGTC in Q1 2017 and held it in 5 quarters. The position peaked at $18K in Q1 2021. 71 funds tracked by Wall St. Rank hold AGTC as of Q2 2021.

Ameritas Investment Partners reported no remaining Applied Genetic Technologies Corporation position as of Q2 2021 after selling out during the quarter.
Ameritas Investment Partners sold 3,532 Applied Genetic Technologies Corporation shares in Q2 2021, an estimated $18K.
Ameritas Investment Partners first reported a position in Applied Genetic Technologies Corporation in Q1 2017 and held it in 5 quarters.
Ameritas Investment Partners's Applied Genetic Technologies Corporation position peaked at $18K in Q1 2021.
71 funds tracked by Wall St. Rank held Applied Genetic Technologies Corporation as of Q2 2021.

Based on Ameritas Investment Partners's 13F filing for Q2 2021, filed 6 Aug 2021.